Hem › Spinal muskelatrofi
Kliniska studier för Spinal muskelatrofi som rekryterar i USA
23 studier för Spinal muskelatrofi rekryterar deltagare vid platser över hela USA.
Städer med flest studier
- Mountain View, CA9 studier
- New York City, NY9 studier
- Philadelphia, PA7 studier
- Chicago, IL6 studier
- Norfolk, VA6 studier
- Grand Rapids, MI6 studier
- Boston, MA5 studier
- Houston, TX5 studier
- Lewisville, TX4 studier
- Little Rock, AR4 studier
- Phoenix, AZ4 studier
- Aurora, CO4 studier
- Memphis, TN3 studier
- Durham, NC3 studier
- Orlando, FL3 studier
- Cedar Rapids, IA3 studier
- Columbia, MO3 studier
- Harrisburg, PA3 studier
- Charlottesville, VA3 studier
- Minneapolis, MN3 studier
- Portland, OR3 studier
- Fort Worth, TX3 studier
- Dallas, TX3 studier
- Gainesville, FL3 studier
- Atlanta, GA3 studier
- Orange, CA3 studier
Efter delstat
- Arizona4 studier
- Arkansas4 studier
- Colorado4 studier
- Florida8 studier
- Georgia3 studier
- Illinois6 studier
- Iowa3 studier
- Kalifornien11 studier
- Massachusetts6 studier
- Michigan6 studier
- Minnesota3 studier
- Missouri4 studier
- New York10 studier
- North Carolina3 studier
- Oregon3 studier
- Pennsylvania8 studier
- Tennessee3 studier
- Texas10 studier
- Virginia7 studier
Nyligen uppdaterade studier
Officiell studietext (engelska)
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy
RekryterarFas 4
3 Months – 24 Months · Alla kön · Uppdaterad 2 okt. 2026 · NCT05861986A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
RekryterarFas 2
Upp till ålder 2 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07047144A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam
RekryterarFas 3
Ålder 15 till 60 · Alla kön · Uppdaterad 2 okt. 2026 · NCT07444476A Registry of Cases of Spinal Muscular Atrophy
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 30 sep. 2026 · NCT07805278ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
RekryterarFas 4
Ålder 2 till 100 · Alla kön · Uppdaterad 18 sep. 2026 · NCT07448610A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
RekryterarFas 2
Ålder 5 till 17 · Alla kön · Uppdaterad 14 sep. 2026 · NCT07287982A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
RekryterarFas 4
3 Months – 24 Months · Alla kön · Uppdaterad 10 sep. 2026 · NCT05861999A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)
RekryterarFas 1
Ålder 3 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT06555419Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
Rekryterar
Ålder 18 till 80 · Alla kön · Uppdaterad 2 sep. 2026 · NCT07521930Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
Rekryterar
Ålder 3 och äldre · Alla kön · Uppdaterad 19 aug. 2026 · NCT05866419A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)
RekryterarFas 3
0 Days – 42 Days · Alla kön · Uppdaterad 18 aug. 2026 · NCT07221669A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
RekryterarFas 3
0 Days – 7 Months · Alla kön · Uppdaterad 11 aug. 2026 · NCT07444450Exploring the Physiologic, Pharmacodynamic, and Clinical Responses of Skeletal Muscle in Patients With Spinal Muscular Atrophy Treated With SMN-Directed Therapies
RekryterarObservationsstudie
Ålder 5 till 20 · Alla kön · Uppdaterad 9 juli 2026 · NCT06532474Clinical Procedures to Support Research in ALS
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 15 juni 2026 · NCT03489278ALS/MND Natural History Study Data Repository
RekryterarObservationsstudie
Ålder 18 till 90 · Alla kön · Uppdaterad 20 maj 2026 · NCT05966038Characterizing Perceived Physical Fatigability in Nusinersen-treated SMA
RekryterarObservationsstudie
Ålder 12 och äldre · Alla kön · Uppdaterad 14 maj 2026 · NCT06955897Establishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
RekryterarObservationsstudieFriska volontärer välkomna
Ålder 5 och äldre · Alla kön · Uppdaterad 9 apr. 2026 · NCT06839469HABIT-ILE + FST in Children With SMA: Preliminary Effectiveness
Rekryterar
Ålder 5 till 17 · Alla kön · Uppdaterad 23 mars 2026 · NCT07488338Gait and Bone Health in SMA
RekryterarObservationsstudie
Ålder 8 till 50 · Alla kön · Uppdaterad 18 mars 2026 · NCT07400198Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
Rekryterar
Ålder 18 och äldre · Alla kön · Uppdaterad 17 mars 2026 · NCT07478172A Study to Learn How Nusinersen (Spinraza) Affects Participants With Spinal Muscular Atrophy (SMA) Who Took it Before or During Pregnancy And About The Health of Their Babies
RekryterarObservationsstudie
Ålder 18 till 54 · Kvinnor · Uppdaterad 9 mars 2026 · NCT05789758Diagnostic Journey, Patient Experience, and Disparities in the Treatment of Spinal Muscular Atrophy (SMA) in the MedStar Health System
RekryterarObservationsstudie
Ålder 18 och äldre · Alla kön · Uppdaterad 16 jan. 2026 · NCT07223489Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
RekryterarObservationsstudie
Alla åldrar · Alla kön · Uppdaterad 31 jan. 2025 · NCT04174157Från ClinicalTrials.gov, data hämtad 5 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.